Parenteral Delivery of Peptides and Proteins - Challenges in Delivery of Therapeutic Genomics and Proteomics - page 598

[154] Timpi P Ramachandran GN, Reddi AH, editors. Biochemistry of collagen. New York,
NY: Plenum Press; 1976. p. 55-78.
[155] Liu Z, Jiao Y, Wang Y, Zhou C, Zhang Z. Polysaccharides-based nanoparticles as drug
delivery systems. Adv Drug Delivery Rev 2008;60:1650-62.
[156] Kida T, Inoue K, Akagi T, Akashi M. Preparation of novel polysaccharide nanoparti-
cles by the self-assembly of amphiphilic pectins and their protein-encapsulation ability.
Chem Lett 2007;36:940.
[157] Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation.
J Pharm Sci 2000;89:850-66.
[158] Artursson P, Edman P, Laakso T, Sjoholm I. Characterization of polyacryl starch mic-
roparticles as carriers for proteins and drugs. J Pharm Sci 1984;73:1507-13.
[159] Chun W, Xiong F, LianSheng Y. Water-soluble chitosan nanoparticles as a novel carrier
system for protein deliver. Chin Sci Bull 2007;52:883-9.
[160] Song Y, Zhou J, Li Q, Guo Y, Zhang L. Preparation and characterization of novel quat-
ernized cellulose nanoparticles as protein carriers. Macromol Biosci 2009;9:857-63.
[161] Olsen D, Yang C, Bodo M, Chang R, Leigh S, Baez J, et al. Recombinant collagen and
gelatin for drug delivery. Adv Drug Delivery Rev 2003;55:1547-67.
[162] Yang C, Hillas PJ, Baez JA, Nokelainen M, Balan J, Tang J, et al. The application of
recombinant human collagen in tissue engineering. BioDrugs 2004;18:103-19.
[163] Malik DK, Baboota S, Ahuja A, Hasan S, Ali J. Recent advances in protein and peptide
drug delivery systems. Curr Drug Deliv 2007;4:141-51.
[164] Balasubramanian V, Onaca O, Enea R, Hughes DW, Palivan CG. Protein delivery:
from conventional drug delivery carriers to polymeric nanoreactors. Expert Opin Drug
Delivery 2010;7:63-78.
[165] Jorgensen L, Moeller EH, van de Weert M, Nielsen HM, Frokjaer S. Preparing and
evaluating delivery systems for proteins. Eur J Pharm Sci 2006;29:174-82.
[166] Lee VHL. Peptide and protein drug delivery: opportunities and challenges. Pharm Int
1986;7:208-12.
[167] Singh J, Pandit S, Bramwell VW, Alpar HO. Diphtheria toxoid loaded poly-(-caprolac-
tone) nanoparticles as mucosal vaccine delivery systems. Methods 2006;38:96-105.
[168] Wyatt BW, Cassels FJ. The encapsulation of enterotoxigenic Escherichia coli coloniza-
tion factor CS3 in biodegradable microspheres enhances the murine antibody response
following intranasal administration. Microbiology 2006;152:779-86.
[169] Desai MP, Hilfinger JM, Amidon GL, Levy RJ, Labhasetwar V. Immune response with
biodegradable nanospheres and alum: studies in rabbits using staphylococcal entero-
toxin Btoxoid. J Microencapsulation 2000;17:215-25.
[170] Dineshkumar B, Dhanaraj SA, Santhi K, Vijayan P, Raghu C. Single dose vaccine deliv-
ery system of tetanus toxoid formulation based on chitosan microspheres. Int J Adv
Pharm Sci 2010;1:42-9.
[171] Zambaux MF, Bonneaux F, Gref R, Dellacherie E, Vigneron C. Protein C-loaded mono-
methoxypoly (ethylene oxide)-poly (lactic acid) nanoparticles. Int J Pharm 2001;212:1-9.
[172] Jun FL, Yong TL, Victor CY. A novel approach for delivery of enzyme drugs: prelimi-
nary demonstration of feasibility and utility in vitro . Int J Pharm 2000;202:11-20.
[173] Prabhu S, Tran LP, Betageri GV. Effect of co-solvents on the controlled release of
calcitonin polypeptide from in situ biodegradable polymer implants. Drug Delivery
2005;12:393-8.
[174] Park SY, Chung HJ, Lee Y, Park TG. Injectable and sustained delivery of human growth
hormone using chemically modified Pluronic copolymer hydrogels. Biotechnol J 2008;3:
669-75.